Advancements in Vaccine Innovation and Global Health Strategies

This chapter explores recent advancements in vaccine technology focused on the Omicron variant, highlighting the work of companies like Moderna and BioNTech. It emphasizes the necessity for diverse vaccine strategies and boosting production capabilities in low and middle-income nations to enhance global health outcomes.